Morgan Stanley’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,694
| Closed | -$159 | – | 8394 |
|
|
2025
Q1 | $159 | Buy |
1,694
+78
| +5% | +$24 | ﹤0.01% | 7500 |
|
|
2024
Q4 | $1.14K | Hold |
1,616
| – | – | ﹤0.01% | 7255 |
|
|
2024
Q3 | $1.31K | Sell |
1,616
-806
| -33% | -$895 | ﹤0.01% | 7191 |
|
|
2024
Q2 | $3.61K | Hold |
2,422
| – | – | ﹤0.01% | 6937 |
|
|
2024
Q1 | $7.51K | Sell |
2,422
-2,126
| -47% | -$9.19K | ﹤0.01% | 6793 |
|
|
2023
Q4 | $18.6K | Buy |
4,548
+2,441
| +116% | +$9.95K | ﹤0.01% | 6690 |
|
|
2023
Q3 | $11.3K | Sell |
2,107
-5,991
| -74% | -$22.6K | ﹤0.01% | 6692 |
|
|
2023
Q2 | $26.8K | Sell |
8,098
-1,381
| -15% | -$5.82K | ﹤0.01% | 6456 |
|
|
2023
Q1 | $52K | Buy |
9,479
+6,031
| +175% | +$40.9K | ﹤0.01% | 6280 |
|
|
2022
Q4 | $17.2K | Sell |
3,448
-2,004
| -37% | -$11K | ﹤0.01% | 6744 |
|
|
2022
Q3 | $31K | Sell |
5,452
-5,104
| -48% | -$54.9K | ﹤0.01% | 6615 |
|
|
2022
Q2 | $93K | Sell |
10,556
-6,111
| -37% | -$62K | ﹤0.01% | 6315 |
|
|
2022
Q1 | $259K | Sell |
16,667
-164,990
| -91% | -$2.86M | ﹤0.01% | 5779 |
|
|
2021
Q4 | $4.82M | Buy |
181,657
+92,058
| +103% | +$3.49M | ﹤0.01% | 3762 |
|
|
2021
Q3 | $4.37M | Buy |
89,599
+84,251
| +1,575% | +$5.21M | ﹤0.01% | 3881 |
|
|
2021
Q2 | $451K | Buy |
5,348
+2,069
| +63% | +$178K | ﹤0.01% | 5592 |
|
|
2021
Q1 | $332K | Sell |
3,279
-4,735
| -59% | -$520K | ﹤0.01% | 5376 |
|
|
2020
Q4 | $806K | Buy |
8,014
+3,541
| +79% | +$236K | ﹤0.01% | 4787 |
|
|
2020
Q3 | $207K | Sell |
4,473
-837
| -16% | -$43K | ﹤0.01% | 5097 |
|
|
2020
Q2 | $306K | Buy |
+5,310
| New | +$355K | ﹤0.01% | 4870 |
|
Other funds holding AWH
Morgan Stanley's AWH Position: Q2 2025 in Review
Morgan Stanley sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q2 2025, closing a stake of 1,694 shares — an estimated $159 sold.
Morgan Stanley first reported a position in AWH in Q2 2020 and held it in 20 quarters. The position peaked at $4.82M in Q4 2021. 2 funds tracked by Wall St. Rank hold AWH as of Q2 2025.
- Morgan Stanley reported no remaining Aspira Women's Health Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
- Morgan Stanley sold 1,694 Aspira Women's Health Inc. Common Stock shares in Q2 2025, an estimated $159.
- Morgan Stanley first reported a position in Aspira Women's Health Inc. Common Stock in Q2 2020 and held it in 20 quarters.
- Morgan Stanley's Aspira Women's Health Inc. Common Stock position peaked at $4.82M in Q4 2021.
- 2 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q2 2025.
Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.